OncoThera BioSolutions develops targeted biologics for cancer using AI, nanoparticle delivery, and patient-specific treatment approaches.
OncoThera BioSolutions has raised $6.6M in total funding. The most recent round was Pre-Seed. The last funding was announced in March 2025.
OncoThera BioSolutions's investors include DH Venture Holdings, Angel investos, Strecker Family Office.
OncoThera BioSolutions is headquartered in London, United Kingdom.
OncoThera BioSolutions develops targeted biologics for cancer using AI, nanoparticle delivery, and patient-specific treatment approaches.
OncoThera BioSolutions is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OncoThera BioSolutions — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/oncothera-biosolutions. Accessed July 19, 2026.
VCBacked. (2025). OncoThera BioSolutions — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/oncothera-biosolutions
{{cite web |title=OncoThera BioSolutions — Funding & Investors |url=https://www.vcbacked.co/company/oncothera-biosolutions |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated